Krishna M. Ella, PhD
About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us
Krishna M. Ella, PhD
Chairman and Managing Director
Bharat Biotech International Limited

Dr. Krishna Ella graduated with a PhD, from the University of Wisconsin-Madison and returned to India in 1996 to start Bharat Biotech. Bharat Biotech focuses on developing vaccines to address neglected diseases that afflict developing world populations.

Having successfully developed 16 vaccines over the past 25 years, that include a portfolio of 11 viral vaccines and over 140 patents, Bharat Biotech has supplied ~9 Billion doses to 123 countries around the world.

Bharat Biotech successfully developed ROTAVAC®, the first vaccine in the developing world to complete efficacy trails in children, under the Indo-US VAP programme. The company augmented its capabilities for developing new vaccines through this bilateral program.

The company also developed TYPBAR TCV®, the world’s first conjugate vaccine for Typhoid, with the successful completion of human challenge studies in Oxford. The company also completed effectiveness clinical studies in 6 countries in collaboration with Oxford University, University of Maryland and CDC.  

Having to its credit that first global patent for Zika virus vaccine, the company has most recently secured funding from CEPI to conduct clinical trials for Chikungunya Vaccine in Thailand, Philippines, Guatemala, India and Colombia. 

Bharat Biotech has proven its capabilities with a track record of having conducted clinical trials with over 6,00,000 volunteers in over 20 countries.  Dr. Ella is grateful for the liberal funding of over USD 300 million in grants from Bill & Melinda Gates Foundation, Welcome Trust and other governments. 

Today, the company forges ahead in innovation against the current COVID-19 pandemic through COVAXIN® and two other vaccines in the pipeline in collaboration with Washington University and Thomas Jefferson University.

© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Legal | Contact us